Monopoly concerns push FTC to sue to block Amgen's more than $26B deal for Horizon
Federal regulators are suing to block biotech drug developer Amgen’s more than $26 billion deal for Horizon Therapeutics
Federal regulators are suing to block biotech drug developer Amgen’s more than $26 billion deal for Horizon Therapeutics
